STERIS Healthcare — Cost of Revenue increased by 4.0% to $615.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 11.4%, from $552.40M to $615.60M. Over 2 years (FY 2023 to FY 2025), Healthcare — Cost of Revenue shows an upward trend with a 11.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests margin compression due to rising input costs or manufacturing inefficiencies, while a decrease indicates improved operational leverage.
This represents the direct costs attributable to the production and delivery of healthcare-related products and services...
Commonly reported as Cost of Goods Sold (COGS) in segment financial disclosures for manufacturing firms.
ste_segment_healthcare_cost_of_revenue| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $447.04M | $447.04M | $447.04M | $447.04M | $520.96M | $520.96M | $520.96M | $520.96M | $511.00M | $541.50M | $552.40M | $599.18M | $557.40M | $592.10M | $615.60M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +16.5% | +0.0% | +0.0% | +0.0% | -1.9% | +6.0% | +2.0% | +8.5% | -7.0% | +6.2% | +4.0% |
| YoY Change | — | — | — | — | +16.5% | +16.5% | +16.5% | +16.5% | -1.9% | +3.9% | +6.0% | +15.0% | +9.1% | +9.3% | +11.4% |